Company Profiles

driven by the PitchBook Platform

Selexis

Selexis
2001 FOUNDED
PRIVATE STATUS
11-50 EMPLOYEES
M&A LATEST DEAL TYPE (Announced)
5 INVESTORS
Description

Developer of cell line generation technologies designed to translate scientific innovation into life-saving medicines for patients. The company's cell line generation technologies develop mammalian biopharmaceuticals for the production of monoclonal antibodies and recombinant proteins, empowering scientists and biopharmaceutical companies around the world to realize the full potential of their research.

Website:
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
14, chemin des Aulx
1228 Plan-les-Ouates
Switzerland
+41 (0)22 308 9360
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Selexis’s full profile, request a free trial.

Selexis Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Jun-2017 Announced Generating Revenue
6. Grant 20-May-2015 Completed Generating Revenue
5. Early Stage VC 01-Mar-2004 Completed Startup
4. Early Stage VC 01-Feb-2003 Completed Startup
3. Debt - General 01-Jun-2002 Completed Startup
2. Seed Round 01-Mar-2001 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Selexis Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Commission pour la Technologie et l'Innovation Other Minority 000 0000 000000 0
Eurostars Government 000 0000 000000 0
Fongit Accelerator/Incubator 000 0000 000000 0
Fongit Seed Invest Venture Capital Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0

Selexis Executive Team (7)

Name Title Board
Seat
Contact
Info
Igor Fisch Ph.D Chief Executive Officer, Chairman & Co-Founder
Regine Brokamp Chief Operating Officer
Pierre-Alain Girod Ph.D Chief Scientific Officer
David Calabrese Ph.D Director, Cell Line Services
Alexandre Regamey Ph.D Director, Molecular Biology
You’re viewing 5 of 7 executives. Get the full list »

Selexis Board Members (5)

Name Representing Role Since Contact
Info
Gian-Luigi Berini Self Board Member 000 0000
Igor Fisch Ph.D Selexis Chief Executive Officer, Chairman & Co-Founder 000 0000
Marcel Schmocker Self Board Member 000 0000
Nicolas Mermod Selexis Co-Founder & Board Member 000 0000
Peter Pfister Ph.D Self Board Member 000 0000